Eisai
4523.T
#2156
Rank
NZ$16.03 B
Marketcap
NZ$56.82
Share price
3.73%
Change (1 day)
11.99%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): NZ$0.64 Billion

According to Eisai's latest financial reports the company's current earnings are NZ$5.44 Billion. In 2025 the company made an earning of NZ$0.76 Billion a decrease over its 2024 earnings that were of NZ$0.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.64 B-15.78%
2025 NZ$0.76 B-20.48%
2024 NZ$0.95 B2.42%
2023 NZ$0.93 B-2404.04%
2022 -NZ$40.57 Million-103.6%
2021 NZ$1.12 B-39.81%
2020 NZ$1.87 B7.44%
2019 NZ$1.74 B17.22%
2018 NZ$1.48 B86.16%
2017 NZ$0.79 B-23.52%
2016 NZ$1.04 B26.97%
2015 NZ$0.82 B22.3%
2014 NZ$0.67 B-46.07%
2013 NZ$1.24 B-21.85%
2012 NZ$1.59 B-20.59%
2011 NZ$2.01 B-8.91%
2010 NZ$2.20 B19.21%
2009 NZ$1.85 B